Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$59.06 - $72.15 $155,327 - $189,754
-2,630 Closed
0 $0
Q2 2019

Jul 19, 2019

BUY
$62.09 - $86.14 $163,296 - $226,548
2,630 New
2,630 $169,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Machina Capital S.A.S. Portfolio

Follow Machina Capital S.A.S. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Machina Capital S.A.S., based on Form 13F filings with the SEC.

News

Stay updated on Machina Capital S.A.S. with notifications on news.